To compare healthcare utilization outcomes for patients diagnosed with focal epilepsy and having cenobamate or one of 7 other newer antiseizure medications (ASMs) added to their treatment regimen.
No takes yet. Share an insight, caveat, or question.
Urban et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: